Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

Total article views   Abstract views HTML views PDF downloads Totals
11,108 Dovepress* 7,599 1,152+ 1,009 8,751
PubMed Central* 0 2,357 369 2,357
Totals 7,599 3,509 1,378 11,108
*Since 12 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar